Low production cost and easy quality control The production process of tablets is relatively mature, and the production equipment is common, which makes the production cost of tablets relatively low
In one small case series, higher combined doses (4 mg BPC-157 + 6 mg TB-500 administered intra-articularly) showed better results compared to lower-dose approaches
The evidence base consists of animal studies (primarily rodent models) and one small case series showing accelerated anal fissure healing with topical BPC-157
Peptide therapy should only be pursued under the guidance of a licensed healthcare professional following applicable laws and regulations in Charleston, South Carolina
Furthermore, TB-500 seemingly reversed the action of DAPT and BMS, which may support its role in regulating these pathways
BPC-157 consists of a short chain of amino acids, which places it in the peptide category from a biochemical standpoint